Kalveer Flora, MPharm: Experience With Biosimilars in Rheumatology

September 9, 2019

Kalveer Flora, MPharm, London North West University Healthcare National Health Service Trust, explains how rheumatology specialists have led the way in biosimilar adoption.

Transcript

In terms of my specialty, which is rheumatology, I think rheumatology pharmacists and rheumatologists have actually led the way in adopting biosimilars, only because we’ve had so much experience with biosimilars compared with dermatologists and gastroenterologists. So I think the rheumatologists have really led the way in providing that real-world evidence, that confidence, that transferrable data.